Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes
NCT01926938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2013-08-21
Summary
Diabetes is a major public health problem. Hispanics/Latinos are known to be at higher risk for type 2 diabetes. The function of the endothelium has played a key role in the understanding of vascular complications in people with diabetes. Endothelial function and vascular reactivity are impaired not only in white adults with type 2 diabetes but also in those at risk for the disease by virtue of having impaired glucose tolerance or parental history of type 2 diabetes. Whether this finding is applicable to hispanics is not known. The investigators plan to assess the endothelial function and vascular reactivity in young Hispanic adults at risk of developing type 2 diabetes by virtue of being obese and belonging to a minority population.
Conditions
Sponsors & Collaborators
-
Joslin Diabetes Center
lead OTHER
Principal Investigators
-
Enrique Caballero, MD · Joslin Diabetes Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Ischemic Preconditioning and Type 2 Diabetes
NCT03598855 ·Status: COMPLETED ·Phase: NA
-
CV Disease in Adolescents With Type 2 Diabetes
NCT00114998 ·Status: COMPLETED
-
Impact of Medicaid Health Home on Patients With Diabetes in New York City
NCT02713321 ·Status: COMPLETED
-
Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes
NCT01813929 ·Status: COMPLETED ·Phase: PHASE4
-
Dissecting Host-microbiome Modifiers of Type 2 Diabetes Risk
NCT04579900 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.
NCT00264940 ·Status: UNKNOWN
-
Personalized Medicine for Diabetes Prediction and Prevention of Complications
NCT01268813 ·Status: UNKNOWN ·Phase: PHASE1
-
Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin
NCT00169624 ·Status: TERMINATED ·Phase: PHASE3
-
Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus
NCT05806502 ·Status: COMPLETED ·Phase: NA
-
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
NCT06682351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Morbidity in Newly Diagnosed type2 Diabetes in Adults
NCT02002091 ·Status: COMPLETED
-
A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes
NCT00318032 ·Status: UNKNOWN ·Phase: NA
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
NCT00814190 ·Status: COMPLETED ·Phase: NA
-
Mechanisms and Reversibility of Heart Failure Associated With Diabetes
NCT01970319 ·Status: COMPLETED
-
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
NCT00589355 ·Status: COMPLETED
-
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
NCT01283113 ·Status: COMPLETED
-
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
NCT05609279 ·Status: COMPLETED
-
Diabetes Mellitus Type II and Tissue Oxygenation
NCT00554697 ·Status: TERMINATED
-
Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.
NCT05333718 ·Status: RECRUITING
-
Implication of Metabolic and Genomic Modifications in Elderly Subjects
NCT00951392 ·Status: COMPLETED ·Phase: NA
-
Diabetes-Related Discrimination at Workplace and by Insurances
NCT00661908 ·Status: COMPLETED
-
Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes
NCT03480945 ·Status: COMPLETED
-
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
NCT01218061 ·Status: UNKNOWN ·Phase: NA
-
Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
NCT00143013 ·Status: UNKNOWN